U.S. markets closed
  • S&P Futures

    4,250.00
    +4.25 (+0.10%)
     
  • Dow Futures

    34,493.00
    +31.00 (+0.09%)
     
  • Nasdaq Futures

    14,021.50
    +27.25 (+0.19%)
     
  • Russell 2000 Futures

    2,333.00
    +2.50 (+0.11%)
     
  • Crude Oil

    71.21
    +0.30 (+0.42%)
     
  • Gold

    1,866.60
    -13.00 (-0.69%)
     
  • Silver

    27.92
    -0.22 (-0.79%)
     
  • EUR/USD

    1.2102
    -0.0004 (-0.04%)
     
  • 10-Yr Bond

    1.4620
    +0.0030 (+0.21%)
     
  • Vix

    15.65
    -0.45 (-2.80%)
     
  • GBP/USD

    1.4110
    -0.0007 (-0.05%)
     
  • USD/JPY

    109.7730
    +0.1380 (+0.13%)
     
  • BTC-USD

    38,851.59
    +3,881.30 (+11.10%)
     
  • CMC Crypto 200

    970.92
    +29.10 (+3.09%)
     
  • FTSE 100

    7,134.06
    +45.88 (+0.65%)
     
  • Nikkei 225

    29,108.65
    +159.92 (+0.55%)
     

Impact Healthcare REIT (LON:IHR) Shareholders Have Enjoyed A 19% Share Price Gain

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.

We believe investing is smart because history shows that stock markets go higher in the long term. But if you choose that path, you're going to buy some stocks that fall short of the market. Over the last year the Impact Healthcare REIT PLC (LON:IHR) share price is up 19%, but that's less than the broader market return. Having said that, the longer term returns aren't so impressive, with stock gaining just 8.2% in three years.

Check out our latest analysis for Impact Healthcare REIT

While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

Over the last twelve months, Impact Healthcare REIT actually shrank its EPS by 13%.

So we don't think that investors are paying too much attention to EPS. Therefore, it seems likely that investors are putting more weight on metrics other than EPS, at the moment.

For starters, we suspect the share price has been buoyed by the dividend, which was increased during the year. Income-seeking investors probably helped bid up the stock price. Furthermore, the revenue growth of 28% probably also encouraged buyers.

The company's revenue and earnings (over time) are depicted in the image below (click to see the exact numbers).

earnings-and-revenue-growth
earnings-and-revenue-growth

Take a more thorough look at Impact Healthcare REIT's financial health with this free report on its balance sheet.

What About Dividends?

It is important to consider the total shareholder return, as well as the share price return, for any given stock. The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. In the case of Impact Healthcare REIT, it has a TSR of 26% for the last year. That exceeds its share price return that we previously mentioned. This is largely a result of its dividend payments!

A Different Perspective

Impact Healthcare REIT produced a TSR of 26% over the last year. Unfortunately this falls short of the market return of around 32%. On the other hand, the TSR over three years was worse, at just 8% per year. This suggests the company's position is improving. If the share price is up as a result of improved business performance, then this kind of improvement may be sustained. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. For instance, we've identified 3 warning signs for Impact Healthcare REIT that you should be aware of.

If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on GB exchanges.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.